New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Pacritinib Pretreatment Demonstrates Intriguing Interim Findings in Myelofibrosis

Pacritinib Pretreatment Demonstrates Intriguing Interim Findings in Myelofibrosis

August 14, 2020Jessica HergertPretreatment with the investigational JAK2/FLT3 inhibitor pacritinib prior to allogeneic stem cell transplant was shown to be feasible and safe in patients with primary,
World medicine November 21,2023
Pacritinib Pretreatment Demonstrates Intriguing Interim Findings in Myelofibrosis

Pacritinib Pretreatment Demonstrates Intriguing Interim Findings in Myelofibrosis

August 14, 2020Jessica HergertPretreatment with the investigational JAK2/FLT3 inhibitor pacritinib prior to allogeneic stem cell transplant was shown to be feasible and safe in patients with primary,
World medicine November 21,2023
John Theurer Cancer Center Scientists Develop Web-Based Intervention Addressing Distress in Caregivers of Patients Receiving Stem Cell Transplants

John Theurer Cancer Center Scientists Develop Web-Based Intervention Addressing Distress in Caregivers of Patients Receiving Stem Cell Transplants

August 7, 2017Onclive TeamA group of researchers from several institutions in the US, including John Theurer Cancer Center, studied the development of a new, web-based intervention - Pep-Pal- to provi
World medicine November 21,2023
John Theurer Cancer Center Scientists Develop Web-Based Intervention Addressing Distress in Caregivers of Patients Receiving Stem Cell Transplants

John Theurer Cancer Center Scientists Develop Web-Based Intervention Addressing Distress in Caregivers of Patients Receiving Stem Cell Transplants

August 7, 2017Onclive TeamA group of researchers from several institutions in the US, including John Theurer Cancer Center, studied the development of a new, web-based intervention - Pep-Pal- to provi
World medicine November 21,2023
FDA Approves Defibrotide for Hepatic VOD Following Stem Cell Transplantation

FDA Approves Defibrotide for Hepatic VOD Following Stem Cell Transplantation

March 30, 2016Silas InmanThe FDA has approved defibrotide sodium as a treatment for severe hepatic veno-occlusive disease with associated kidney or lung abnormalities following hematopoietic stem cell
World medicine November 21,2023
FDA Approves Defibrotide for Hepatic VOD Following Stem Cell Transplantation

FDA Approves Defibrotide for Hepatic VOD Following Stem Cell Transplantation

March 30, 2016Silas InmanThe FDA has approved defibrotide sodium as a treatment for severe hepatic veno-occlusive disease with associated kidney or lung abnormalities following hematopoietic stem cell
World medicine November 21,2023
Rolling Submission Completed for Daratumumab/Rd in Frontline Transplant-Ineligible Myeloma

Rolling Submission Completed for Daratumumab/Rd in Frontline Transplant-Ineligible Myeloma

March 13, 2019Gina ColumbusJason M. BroderickA supplemental biologics license application has been submitted to the FDA for the approval of daratumumab in combination with lenalidomide and dexamethaso
World medicine November 21,2023
Rolling Submission Completed for Daratumumab/Rd in Frontline Transplant-Ineligible Myeloma

Rolling Submission Completed for Daratumumab/Rd in Frontline Transplant-Ineligible Myeloma

March 13, 2019Gina ColumbusJason M. BroderickA supplemental biologics license application has been submitted to the FDA for the approval of daratumumab in combination with lenalidomide and dexamethaso
World medicine November 21,2023
Daratumumab Plus VRd Shows Improved sCR in Transplant-Eligible, Newly Diagnosed Myeloma

Daratumumab Plus VRd Shows Improved sCR in Transplant-Eligible, Newly Diagnosed Myeloma

September 15, 2019Lynne Lederman, PhDThe addition of daratumumab to bortezomib, lenalidomide, and dexamethasone for transplant-eligible patients with newly diagnosed multiple myeloma improved the dept
World medicine November 21,2023
Daratumumab Plus VRd Shows Improved sCR in Transplant-Eligible, Newly Diagnosed Myeloma

Daratumumab Plus VRd Shows Improved sCR in Transplant-Eligible, Newly Diagnosed Myeloma

September 15, 2019Lynne Lederman, PhDThe addition of daratumumab to bortezomib, lenalidomide, and dexamethasone for transplant-eligible patients with newly diagnosed multiple myeloma improved the dept
World medicine November 21,2023
Blinatumomab Approved in Europe for Pediatric ALL

Blinatumomab Approved in Europe for Pediatric ALL

August 29, 2018Jason M. BroderickThe European Commission has approved blinatumomab for the treatment of pediatric patients with Philadelphia chromosome–negative, CD19-positive B-cell precursor acute l
World medicine November 21,2023
Blinatumomab Approved in Europe for Pediatric ALL

Blinatumomab Approved in Europe for Pediatric ALL

August 29, 2018Jason M. BroderickThe European Commission has approved blinatumomab for the treatment of pediatric patients with Philadelphia chromosome–negative, CD19-positive B-cell precursor acute l
World medicine November 21,2023
20 Types of Foods That Lower Blood Pressure

20 Types of Foods That Lower Blood Pressure

ByLindsey DeSoto, RD, LDPublished on August 24, 2023Medically reviewed byElizabeth Barnes, RDNEating a healthy diet is one way to help lower high blood pressure (hypertension)
World medicine November 21,2023
20 Types of Foods That Lower Blood Pressure

20 Types of Foods That Lower Blood Pressure

ByLindsey DeSoto, RD, LDPublished on August 24, 2023Medically reviewed byElizabeth Barnes, RDNEating a healthy diet is one way to help lower high blood pressure (hypertension)
World medicine November 21,2023
11 Best Herbs and Supplements for High Blood Pressure

11 Best Herbs and Supplements for High Blood Pressure

ByLauren Panoff, MPH, RDPublished on January 11, 2023Medically reviewed byElizabeth Barnes, RDNHigh blood pressure, or hypertension, affects 1 in 3 adults in the United States.
World medicine November 21,2023
11 Best Herbs and Supplements for High Blood Pressure

11 Best Herbs and Supplements for High Blood Pressure

ByLauren Panoff, MPH, RDPublished on January 11, 2023Medically reviewed byElizabeth Barnes, RDNHigh blood pressure, or hypertension, affects 1 in 3 adults in the United States.
World medicine November 21,2023
Everything You Need to Know About NAD+ Supplements

Everything You Need to Know About NAD+ Supplements

ByMegan Nunn, PharmDUpdated on November 15, 2023Medically reviewed bySuzanne Fisher, RD窗体顶端Oxidized nicotinamide adenine dinucleotide(NAD+) is crucial to over 500 enzyme
World medicine November 21,2023
Everything You Need to Know About NAD+ Supplements

Everything You Need to Know About NAD+ Supplements

ByMegan Nunn, PharmDUpdated on November 15, 2023Medically reviewed bySuzanne Fisher, RD窗体顶端Oxidized nicotinamide adenine dinucleotide(NAD+) is crucial to over 500 enzyme
World medicine November 21,2023
Goji Berry: Nutrition and Benefits

Goji Berry: Nutrition and Benefits

ByMegan Nunn, PharmDUpdated on November 07, 2023Medically reviewed byAllison Herries, RDNGoji berries are bright red with a sweet, tangy flavor and grow on a shrub native to As
World medicine November 21,2023
Goji Berry: Nutrition and Benefits

Goji Berry: Nutrition and Benefits

ByMegan Nunn, PharmDUpdated on November 07, 2023Medically reviewed byAllison Herries, RDNGoji berries are bright red with a sweet, tangy flavor and grow on a shrub native to As
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com